# COL4A2

## Overview
The COL4A2 gene encodes the collagen type IV alpha 2 chain, a vital component of the basement membrane, which is a specialized structure that supports and separates different tissue types. This gene is part of the collagen family, specifically encoding a protein that forms a triple helix structure with other collagen IV chains, such as COL4A1, to create a stable network essential for basement membrane integrity (Jeanne2012COL4A2). The collagen type IV alpha 2 chain is involved in various biological processes, including cell adhesion, migration, and tissue development, particularly within the vascular system (Sand2016Type). Mutations in COL4A2 are linked to several disorders, including cerebrovascular diseases and renal pathologies, highlighting its clinical significance (Meuwissen2015The; Jeanne2017Genotypephenotype). Understanding the function and interactions of the collagen type IV alpha 2 chain is crucial for elucidating its role in health and disease.

## Structure
The COL4A2 gene encodes the collagen type IV alpha 2 chain, a crucial component of the basement membrane. The protein structure includes a long triple-helical domain flanked by non-collagenous (NC1) domains. The primary structure of COL4A2 consists of 1712 amino acids, with a significant portion forming a collagenous domain characterized by Gly-X-Y repeats, where X and Y are variable amino acids, often proline (Jeanne2017Genotypephenotype; Kuo2012COL4A1). This domain is interrupted by over 20 non-collagenous interruptions, which provide flexibility and include protein interaction domains (Jeanne2017Genotypephenotype).

The secondary structure involves the formation of a triple helix, stabilized by hydroxylation of proline and lysine residues, which are critical for the structural integrity of the protein (Kuo2012COL4A1). The tertiary structure is characterized by the folding of these helices, with the NC1 domain forming a globular structure stabilized by disulfide bonds (Harvey2005Type).

In terms of quaternary structure, COL4A2 forms heterotrimers with COL4A1, essential for the structural integrity of basement membranes. These heterotrimers are assembled in the endoplasmic reticulum and transported to the Golgi apparatus for secretion (Jeanne2017Genotypephenotype). Post-translational modifications, such as glycosylation and hydroxylation, are crucial for proper folding and stability (Parkin2011Mapping; Kuo2012COL4A1).

## Function
The COL4A2 gene encodes the alpha-2 chain of type IV collagen, which is a critical component of basement membranes in various tissues. In healthy human cells, COL4A2, along with COL4A1, forms heterotrimers that are essential for the structural integrity and function of basement membranes. These heterotrimers are synthesized in the endoplasmic reticulum (ER), where they undergo proper folding and post-translational modifications before being secreted into the extracellular matrix (Jeanne2012COL4A2; Kuo2012COL4A1).

The heterotrimers polymerize into flexible sheets in the extracellular space, providing structural strength to basement membranes and participating in dynamic biological processes through interactions with growth factors and cell surface receptors, such as integrins (Jeanne2012COL4A2). The proper secretion and assembly of COL4A2 are crucial for maintaining vascular integrity and preventing conditions such as hemorrhagic stroke (Jeanne2012COL4A2).

COL4A2 is involved in cell adhesion, migration, and tissue development, particularly in the vascular system. It plays a role in maintaining the structural integrity of basement membranes, which is vital for normal cellular functions and organismal outcomes, including vascular health and kidney function (Sand2016Type).

## Clinical Significance
Mutations in the COL4A2 gene are associated with a range of cerebrovascular and systemic disorders. These mutations can lead to conditions such as porencephaly, a cerebrovascular lesion characterized by cystic cavities in the brain, and are linked to small-vessel disease and intracerebral hemorrhages (Meuwissen2015The; Jeanne2017Genotypephenotype). Neurological manifestations include epilepsy, often resistant to antiepileptic drugs, and focal seizures, with brain MRI findings showing porencephalic cysts and white matter abnormalities (Zagaglia2018Neurologic).

COL4A2 mutations also contribute to renal pathologies, with specific mutations like Col4a2 G646D having a severe impact on albuminuria, indicating a significant role in nephropathy (Jeanne2017Genotypephenotype). Ocular conditions such as cataracts and microcornea, as well as systemic manifestations like myopathy and cardiac arrhythmias, are also associated with these mutations (Meuwissen2015The; Jeanne2017Genotypephenotype).

The phenotypic spectrum of COL4A2 mutations is broad, with variable expressivity and incomplete penetrance, leading to diverse clinical presentations across different individuals and families (HausmanKedem2021Deletion). Understanding these genotype-phenotype correlations is crucial for patient management and genetic counseling.

## Interactions
The COL4A2 gene encodes the alpha-2 chain of type IV collagen, which is a critical component of basement membranes. This protein interacts with several other proteins, playing a significant role in various cellular processes. COL4A2 forms a triple helix structure with other collagen IV chains, such as COL4A1, to create a stable network essential for basement membrane integrity (Jeanne2012COL4A2).

COL4A2 interacts with integrins, specifically α1β1 and α2β1, which are crucial for cell adhesion. These interactions are dependent on the triple-helical structure of collagen IV, with specific binding sites located on the collagen IV structure (KERN1993Interaction). The presence of metal ions like Mn2+ enhances these interactions, indicating the importance of the structural conformation for binding affinity (KERN1993Interaction).

The protein also binds to von Willebrand factor (VWF) and glycoprotein VI, suggesting roles in platelet function and vascular biology (Parkin2011Mapping). Laminin and nidogen also interact with COL4A2, contributing to the structural and functional complexity of the extracellular matrix (Parkin2011Mapping). These interactions highlight the multifaceted role of COL4A2 in maintaining cellular and tissue homeostasis.


## References


[1. (KERN1993Interaction) Andreas KERN, Johannes EBLE, Ralph GOLBIK, and Klaus KÜHN. Interaction of type iv collagen with the isolated integrins α1β1 and α2β1. European Journal of Biochemistry, 215(1):151–159, July 1993. URL: http://dx.doi.org/10.1111/j.1432-1033.1993.tb18017.x, doi:10.1111/j.1432-1033.1993.tb18017.x. This article has 179 citations.](https://doi.org/10.1111/j.1432-1033.1993.tb18017.x)

[2. (Jeanne2012COL4A2) Marion Jeanne, Cassandre Labelle-Dumais, Jeff Jorgensen, W. Berkeley Kauffman, Grazia M. Mancini, Jack Favor, Valerie Valant, Steven M. Greenberg, Jonathan Rosand, and Douglas B. Gould. Col4a2 mutations impair col4a1 and col4a2 secretion and cause hemorrhagic stroke. The American Journal of Human Genetics, 90(1):91–101, January 2012. URL: http://dx.doi.org/10.1016/j.ajhg.2011.11.022, doi:10.1016/j.ajhg.2011.11.022. This article has 165 citations.](https://doi.org/10.1016/j.ajhg.2011.11.022)

[3. (HausmanKedem2021Deletion) Moran Hausman-Kedem, Liat Ben-Sira, Debora Kidron, Shay Ben-Shachar, Rachel Straussberg, Daphna Marom, Penina Ponger, Anat Bar-Shira, Gustavo Malinger, and Aviva Fattal-Valevski. Deletion in col4a2 is associated with a three-generation variable phenotype: from fetal to adult manifestations. European Journal of Human Genetics, 29(11):1654–1662, April 2021. URL: http://dx.doi.org/10.1038/s41431-021-00880-3, doi:10.1038/s41431-021-00880-3. This article has 9 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1038/s41431-021-00880-3)

[4. (Sand2016Type) J.M.B. Sand, F. Genovese, and M.A. Karsdal. Type IV Collagen, pages 31–41. Elsevier, 2016. URL: http://dx.doi.org/10.1016/B978-0-12-809847-9.00004-0, doi:10.1016/b978-0-12-809847-9.00004-0. This article has 52 citations.](https://doi.org/10.1016/B978-0-12-809847-9.00004-0)

[5. (Jeanne2017Genotypephenotype) Marion Jeanne and Douglas B Gould. Genotype-phenotype correlations in pathology caused by collagen type iv alpha 1 and 2 mutations. Matrix Biology, 57–58:29–44, January 2017. URL: http://dx.doi.org/10.1016/j.matbio.2016.10.003, doi:10.1016/j.matbio.2016.10.003. This article has 87 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1016/j.matbio.2016.10.003)

[6. (Kuo2012COL4A1) D. S. Kuo, C. Labelle-Dumais, and D. B. Gould. Col4a1 and col4a2 mutations and disease: insights into pathogenic mechanisms and potential therapeutic targets. Human Molecular Genetics, 21(R1):R97–R110, August 2012. URL: http://dx.doi.org/10.1093/hmg/dds346, doi:10.1093/hmg/dds346. This article has 236 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1093/hmg/dds346)

[7. (Parkin2011Mapping) J. Des Parkin, James D. San Antonio, Vadim Pedchenko, Billy Hudson, Shane T. Jensen, and Judy Savige. Mapping structural landmarks, ligand binding sites, and missense mutations to the collagen iv heterotrimers predicts major functional domains, novel interactions, and variation in phenotypes in inherited diseases affecting basement membranes. Human Mutation, 32(2):127–143, January 2011. URL: http://dx.doi.org/10.1002/humu.21401, doi:10.1002/humu.21401. This article has 128 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1002/humu.21401)

[8. (Zagaglia2018Neurologic) Sara Zagaglia, Christina Selch, Jelena Radic Nisevic, Davide Mei, Zuzanna Michalak, Laura Hernandez-Hernandez, S. Krithika, Katharina Vezyroglou, Sophia M. Varadkar, Alexander Pepler, Saskia Biskup, Miguel Leão, Jutta Gärtner, Andreas Merkenschlager, Michaela Jaksch, Rikke S. Møller, Elena Gardella, Britta Schlott Kristiansen, Lars Kjærsgaard Hansen, Maria Stella Vari, Katherine L. Helbig, Sonal Desai, Constance L. Smith-Hicks, Naomi Hino-Fukuyo, Tiina Talvik, Rael Laugesaar, Pilvi Ilves, Katrin Õunap, Ingrid Körber, Till Hartlieb, Manfred Kudernatsch, Peter Winkler, Mareike Schimmel, Anette Hasse, Markus Knuf, Jan Heinemeyer, Christine Makowski, Sondhya Ghedia, Gopinath M. Subramanian, Pasquale Striano, Rhys H. Thomas, Caroline Micallef, Maria Thom, David J. Werring, Gerhard Josef Kluger, J. Helen Cross, Renzo Guerrini, Simona Balestrini, and Sanjay M. Sisodiya. Neurologic phenotypes associated with col4a1 / 2 mutations: expanding the spectrum of disease. Neurology, November 2018. URL: http://dx.doi.org/10.1212/wnl.0000000000006567, doi:10.1212/wnl.0000000000006567. This article has 102 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1212/wnl.0000000000006567)

[9. (Meuwissen2015The) Marije E.C. Meuwissen, Dicky J.J. Halley, Liesbeth S. Smit, Maarten H. Lequin, Jan M. Cobben, René de Coo, Jeske van Harssel, Suzanne Sallevelt, Gwendolyn Woldringh, Marjo S. van der Knaap, Linda S. de Vries, and Grazia M.S. Mancini. The expanding phenotype of col4a1 and col4a2 mutations: clinical data on 13 newly identified families and a review of the literature. Genetics in Medicine, 17(11):843–853, November 2015. URL: http://dx.doi.org/10.1038/gim.2014.210, doi:10.1038/gim.2014.210. This article has 215 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/gim.2014.210)

[10. (Harvey2005Type) Scott J. Harvey and Paul S. Thorner. Type IV collagen: A network for development, differentiation, and disease, pages 1–64. Elsevier, 2005. URL: http://dx.doi.org/10.1016/s1574-3349(05)15001-7, doi:10.1016/s1574-3349(05)15001-7. This article has 3 citations.](https://doi.org/10.1016/s1574-3349(05)15001-7)